Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zi Liu

Showing results (361-370 of 377) with videos related to

Pageof 38
Sort By:
Frontiers in Pharmacology|November 4, 2021
Pyruvate Kinase M2 Mediates Glycolysis Contributes to Psoriasis by Promoting Keratinocyte ProliferationYun-Zi Liu, Ming-Yuan Xu, Xiao-Yu Dai, et al.
Theranostics|December 18, 2018
Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinomaLi-Jie Ma, Fei-Ling Feng, Liang-Qing Dong, et al.
The American Journal of Clinical Nutrition|August 3, 2025
Associations of breastfeeding with maternal and child health outcomes: umbrella reviewJia-Zi Liu, Min-Qi Liao, Lu Zheng, et al.
Journal of Hepatology|March 20, 2018
Spatial and temporal clonal evolution of intrahepatic cholangiocarcinomaLiang-Qing Dong, Yang Shi, Li-Jie Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Bortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cellsHai-Tong Fang, Bo Zhang, Xiao-Fen Pan, et al.
Hepatology (Baltimore, Md.)|February 17, 2025
Erratum: CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinomaLong-Zi Liu, Zhao Zhang, Bo-Hao Zheng, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular CarcinomaLong-Zi Liu, Zhao Zhang, Bo-Hao Zheng, et al.
BMC Cancer|January 29, 2026
Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a multi-center large cohort studyXi-Lin Yang, Jian-Li He, Tie-Jun Wang, et al.
The Oncologist|October 16, 2025
Different prognosis for stage IIB cervical cancer patients with unilateral or bilateral parametrial invasion treated with concurrent chemoradiotherapyXi-Lin Yang, Li-Chun Wei, Jian-Li He, et al.
Hepatology (Baltimore, Md.)|February 18, 2025
Erratum: Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transitionZhi-Chao Wang, Qiang Gao, Jie-Yi Shi, et al.
Pageof 38

Showing results (361-370 of 377) with videos related to

Sort By:
Pageof 38
Frontiers in Pharmacology|November 4, 2021
Pyruvate Kinase M2 Mediates Glycolysis Contributes to Psoriasis by Promoting Keratinocyte ProliferationYun-Zi Liu, Ming-Yuan Xu, Xiao-Yu Dai, et al.
Theranostics|December 18, 2018
Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinomaLi-Jie Ma, Fei-Ling Feng, Liang-Qing Dong, et al.
The American Journal of Clinical Nutrition|August 3, 2025
Associations of breastfeeding with maternal and child health outcomes: umbrella reviewJia-Zi Liu, Min-Qi Liao, Lu Zheng, et al.
Journal of Hepatology|March 20, 2018
Spatial and temporal clonal evolution of intrahepatic cholangiocarcinomaLiang-Qing Dong, Yang Shi, Li-Jie Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Bortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cellsHai-Tong Fang, Bo Zhang, Xiao-Fen Pan, et al.
Hepatology (Baltimore, Md.)|February 17, 2025
Erratum: CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinomaLong-Zi Liu, Zhao Zhang, Bo-Hao Zheng, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular CarcinomaLong-Zi Liu, Zhao Zhang, Bo-Hao Zheng, et al.
BMC Cancer|January 29, 2026
Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a multi-center large cohort studyXi-Lin Yang, Jian-Li He, Tie-Jun Wang, et al.
The Oncologist|October 16, 2025
Different prognosis for stage IIB cervical cancer patients with unilateral or bilateral parametrial invasion treated with concurrent chemoradiotherapyXi-Lin Yang, Li-Chun Wei, Jian-Li He, et al.
Hepatology (Baltimore, Md.)|February 18, 2025
Erratum: Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transitionZhi-Chao Wang, Qiang Gao, Jie-Yi Shi, et al.
Pageof 38